In Mumbai’s private tertiary hospitals, children’s open heart surgery costs roughly between Rs 3 lakh and Rs 10 lakh depending on the defect, the complexity of the repair and the hospital tier. Simple VSD or ASD repairs sit at the lower end. Complex congenital corrections like TOF repair, arterial switch or Fontan procedures push significantly higher. The defect and the centre determine the number far more than any published price list does.

“Families call asking for a cost before they’ve even had an echo and I understand why. But giving a number before knowing the defect, the anatomy and what the repair actually involves would be like quoting a construction price before seeing the building,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

Not one figure covers every child. The cost shifts significantly based on variables that are specific to each case and each centre and understanding them stops families from being blindsided when the actual estimate arrives.

• Defect complexity: A straightforward VSD closure on bypass costs far less than a tetralogy of Fallot repair, a complete AVSD correction or an arterial switch operation for transposition and the surgical time, bypass duration and post-operative ICU requirement all scale with complexity.
• ICU duration: This is usually the biggest variable families underestimate because a child who spends two days in cardiac ICU and one who spends ten days in the same unit after the same procedure can have final bills that differ by Rs 2 to 3 lakh from that single line item alone.
• Hospital tier: A charitable or government-aided cardiac centre in Mumbai charges significantly less than a premium private hospital for an equivalent procedure and the gap can be Rs 2 to 4 lakh on the same surgery without necessarily reflecting a difference in surgical outcome for standard defects.
• Implants and devices: Some repairs require prosthetic valves, conduits, pericardial patches or other implantable materials that are billed separately from the surgical fee and these costs vary by brand, size and whether Indian or imported equivalents are used.

Understanding what open heart surgery involves for a child’s specific defect and what the recovery looks like is exactly what a thorough pediatric heart failure management consultation maps out before any surgical planning begins.

More than most families expect upfront.

• Pre-surgical workup: Echo, ECG, chest X-ray, blood work, cardiac catheterisation for pressure measurements and anaesthesia assessment all happen before the operation and these carry their own charges that rarely appear in the initial surgery quote families receive.
• Anaesthesia fees: Paediatric cardiac anaesthesia is a subspecialty in itself and the anaesthesiologist’s fee in a private Mumbai hospital is billed separately from the surgical fee and can add Rs 30,000 to Rs 80,000 depending on procedure length and complexity.
• Post-operative medications: Diuretics, anticoagulants, cardiac medications and antibiotics through the recovery period add up across the hospital stay and the first weeks at home and these ongoing medication costs continue well beyond the discharge date.
• Follow-up echos and outpatient visits: Open heart surgery in a child doesn’t end at discharge because echo surveillance at one month, three months, six months and annually thereafter carries its own cost across years and this long tail of follow-up is something families need to budget for from the start not discover later.

Parents wanting to understand what the warning signs of an unrepaired cardiac defect look like before surgery becomes urgent should read this piece on top 5 warning signs of pediatric heart failure because recognising deterioration early is what keeps the surgical window open and the options on the table.

Surgical cost planning for a child’s heart condition needs someone who can tell a family exactly what procedure the anatomy requires, what that realistically costs at a centre that does it well and what the follow-up looks like across the years after the operation. Not a quote pulled from a brochure. A real conversation based on the actual echo in front of them. Dr. Prashant Bobhate has spent over 12 years working at the intersection of interventional cardiology and surgical co-management across congenital defects of every complexity at the Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital. Escorts Heart Institute New Delhi. Fellowship at University of Alberta Canada. Over 400 children on active cardiac therapies right now. He tells families what the heart needs, what it costs and what happens next without dressing any of it up.

📞 Call Now: (+91) 8080 826 898 A proper assessment tells you exactly what surgery your child needs, what it realistically costs at a centre equipped to do it well and what the recovery and follow-up plan looks like from day one.

• Congenital Heart Defects, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/congenitalheartdefects.html
• Congenital Heart Defects, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects

Device closure in India in 2026 costs roughly between Rs 1.5 lakh and Rs 3.5 lakh depending on the hospital, the device used and the city. Open heart surgical repair runs higher, typically between Rs 2.5 lakh and Rs 6 lakh or more at private tertiary centres. But the more important number isn’t the cost. It’s whether the anatomy supports device closure at all because that single question changes the entire cost picture.

“Families often come in having already looked up prices online and the number they find rarely matches what their child’s specific situation actually costs because the defect size, the device choice and whether surgery is even avoidable are all variables that a price list can’t account for” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

Not one number fits every child. The cost of ASD closure depends on several variables that shift significantly from one case to the next and understanding them is what stops families from being surprised when the estimate arrives.

• Device vs surgery: Catheter-based device closure is almost always cheaper than open heart surgery because it avoids the operating theatre, cardiopulmonary bypass, ICU admission and the extended hospital stay that surgical repair requires.
• Device cost itself: The occluder device used in catheter closure is the single largest cost driver in a transcatheter procedure and the price varies depending on brand, size and whether a domestic or imported device is used for that specific defect anatomy.
• Hospital tier: A government or trust hospital will quote significantly less than a premium private tertiary centre for the same procedure and the gap between the two can be substantial without necessarily reflecting a difference in surgical outcome for straightforward cases.
• Defect complexity: A simple mid-septal secundum ASD with good rims costs less to close than a defect with multiple fenestrations, a deficient rim needing a larger device or an anatomy that requires intraoperative TOE guidance throughout a technically demanding catheterisation.

Every child being assessed for ASD closure deserves a detailed structural workup and atrial septal defect evaluation maps the anatomy properly before any cost estimate means anything at all.

The procedure cost is only part of the picture.

• Pre-procedure workup: Echo, ECG, chest X-ray, blood investigations and in some cases a cardiac MRI or catheterisation for pressure assessment all add to the total before the closure itself happens and families need to factor these in from the start.
• Anaesthesia and OT charges: These are billed separately in most private hospitals and can add Rs 20,000 to Rs 60,000 on top of the procedure estimate depending on the complexity and duration of the catheterisation or surgical session.
• ICU and ward stay: Device closure typically means one to two nights in hospital while surgical repair means a minimum of five to seven days and the daily room and ICU charges in a private tertiary centre accumulate faster than most families expect when they first see the procedure quote.
• Follow-up echos: A device closure requires echo at one month, three months and six months post procedure to confirm device position and residual shunting and these follow-up visits carry their own charges that are rarely included in the initial procedure estimate families receive.

Parents wanting to understand what happens when an ASD goes unrepaired for too long and the pressure consequences that follow should read this piece on when lung transplant becomes necessary for pulmonary hypertension because the cost of delayed correction is always higher than the cost of timely intervention.

Cost transparency matters but so does getting the right procedure recommendation in the first place because a family that pushes for device closure on an anatomy that needs surgery doesn’t save money they create a more complicated and expensive situation down the line. Dr. Prashant Bobhate has spent over 12 years performing catheter-based ASD closures and managing surgical referral pathways for defects where device closure isn’t the right answer at the Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital.

• Atrial Septal Defect, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/ency/article/000097.htm
• Congenital Heart Defects, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects

A pediatric cardiologist diagnoses heart conditions, manages them with medications and performs catheter-based procedures inside the heart without opening the chest. A pediatric cardiac surgeon operates. Opens the chest, works directly on the heart muscle, valves and vessels under cardiopulmonary bypass. Different training, different skills and in most cases a child needs both working together not one instead of the other.

“Families often arrive confused about who they’re seeing and why. The cardiologist is usually the one who finds the problem, decides what it needs and then brings the surgeon in when an operation is the answer. We work as a team not as alternatives to each other,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India

The cardiologist is almost always the first specialist a child with a suspected heart problem sees and the one who stays involved across the longest stretch of that child’s cardiac life.

• Diagnosis: Echo, ECG, Holter monitoring, exercise testing, cardiac catheterisation for pressure measurements and in some cases MRI interpretation all sit within the cardiologist’s domain before any surgical decision gets made.
• Medical management: Medications for heart failure, pulmonary hypertension, arrhythmia and post-surgical recovery are all prescribed and adjusted by the cardiologist across months and years of follow up not handed off after one appointment.
• Catheter procedures: Balloon valvuloplasty, ASD and VSD device closure, coil embolisation of a PDA and electrophysiology studies all happen in the catheterisation laboratory without a surgical incision and the outcomes in experienced hands are excellent for the right anatomy.
• Long term surveillance: A child who had open heart surgery at three months still needs an echocardiogram at eight, fourteen and twenty-two and that longitudinal relationship across decades belongs to the cardiologist not the surgeon who operated once and stepped back.

If your child has been referred for assessment, understanding what interventional pediatric cardiology involves is a good place to start before the first appointment so the conversation makes sense when it happens.

A completely different disease. The valve is fine. The problem is deeper inside the lungs.

• Vessel walls are the problem: In pulmonary hypertension the small arteries inside the lung tissue thicken, stiffen and narrow from the inside out and that progressive vascular resistance is what forces the right heart to push harder against a resistance it can never physically remove with a catheter balloon.
• Multiple causes: PH can be idiopathic, secondary to congenital heart disease, autoimmune conditions, chronic lung disease or genetic mutations and identifying the underlying cause is what determines which drug pathway gets targeted first.
• Treated with medications not procedures: Unlike stenosis there’s no valve to open or obstruction to cross because the resistance is distributed across millions of tiny vessels inside both lungs and management means targeted drug combinations working on specific molecular pathways simultaneously.
• Progressive without treatment: Untreated pulmonary hypertension causes progressive right heart failure over months to years and the window for getting combination therapy started early before irreversible vascular remodelling sets in is something that genuinely cannot be recovered once it closes.

Families wanting to understand what the treatment journey for pulmonary hypertension actually looks like in real patients should read this piece on sotatercept changing how PAH is managed because the gap between what was possible two years ago and what’s achievable now for PH patients is significant and still widening.

When a child has a heart condition the family needs a cardiologist who can do the diagnostic workup, perform the catheter procedure if the anatomy supports it and coordinate surgical planning when it doesn’t. All three in one place, not scattered across referrals that take weeks. Dr. Prashant Bobhate has spent over 12 years working at exactly that intersection of interventional cardiology and surgical co-management across congenital defects, pulmonary hypertension, arrhythmia and valve disease at the Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital

• Congenital Heart Defects, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/congenitalheartdefects.html
• Congenital Heart Defects, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects

No, not even close. Pulmonary stenosis is a structural problem where the pulmonary valve is narrowed and obstructs blood from flowing out of the right ventricle. Pulmonary hypertension is a pressure problem where the blood vessels inside the lungs become abnormally resistant to flow. Same word at the front. Completely different diseases, different mechanisms and very different treatment paths.

“I explain it this way every time. Stenosis is a blocked gate. Hypertension is a flooded road. Both stress the right heart but for entirely different reasons and treating one like the other would be a serious mistake,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

Pulmonary stenosis is a congenital structural defect. The valve leaflets are thickened, fused or malformed and that physical obstruction is what forces the right ventricle to generate higher pressure just to push blood through a narrowed opening it was never designed to fight against.

• The valve is the problem: In pulmonary stenosis the obstruction sits at the valve itself and the right ventricle thickens over time trying to overcome that fixed mechanical resistance with every single beat.
• Usually congenital: Most cases are present from birth, often picked up on fetal echo or early newborn screening, and mild stenosis can sit quietly for years while severe stenosis in a newborn needs intervention within days.
• Balloon valvuloplasty fixes it: Moderate to severe pulmonary stenosis is treated by inflating a catheter balloon across the narrowed valve to split the fused leaflets open and the results in experienced hands are excellent without open heart surgery in most cases.
• Pressure normalises after treatment: Once the obstruction is relieved the right ventricular pressure drops, the ventricle gradually de-thickens and most children go on to live entirely normal cardiac lives with periodic echo surveillance to confirm the valve stays adequate.

Understanding exactly what the pulmonary valve looks like and how much obstruction it’s generating is the first thing a proper pulmonary hypertension and structural evaluation maps out before anyone makes a management decision.

A completely different disease. The valve is fine. The problem is deeper inside the lungs.

• Vessel walls are the problem: In pulmonary hypertension the small arteries inside the lung tissue thicken, stiffen and narrow from the inside out and that progressive vascular resistance is what forces the right heart to push harder against a resistance it can never physically remove with a catheter balloon.
• Multiple causes: PH can be idiopathic, secondary to congenital heart disease, autoimmune conditions, chronic lung disease or genetic mutations and identifying the underlying cause is what determines which drug pathway gets targeted first.
• Treated with medications not procedures: Unlike stenosis there’s no valve to open or obstruction to cross because the resistance is distributed across millions of tiny vessels inside both lungs and management means targeted drug combinations working on specific molecular pathways simultaneously.
• Progressive without treatment: Untreated pulmonary hypertension causes progressive right heart failure over months to years and the window for getting combination therapy started early before irreversible vascular remodelling sets in is something that genuinely cannot be recovered once it closes.

Families wanting to understand what the treatment journey for pulmonary hypertension actually looks like in real patients should read this piece on sotatercept changing how PAH is managed because the gap between what was possible two years ago and what’s achievable now for PH patients is significant and still widening.

You need someone who can look at a right ventricular pressure of 80mmHg on echo and tell you immediately whether that’s coming from a stenotic valve that a balloon can fix in one sitting or from pulmonary vascular disease that needs a three-drug combination and a decade of follow up. Those are not the same conversation and they don’t belong with the same cardiologist. Dr. Prashant Bobhate has spent over 12 years managing both structural right heart disease including pulmonary stenosis and balloon valvuloplasty and complex pulmonary hypertension across every cause and every age group at the Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital.

• Pulmonary Stenosis, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/ency/article/001096.htm
• Pulmonary Arterial Hypertension, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/pulmonary-hypertension

Neither is universally better. Device closure is less invasive, faster recovery, no chest opening, but it only works for specific ASD types and sizes where the anatomy actually supports a device sitting securely inside the defect. Open heart surgery works for virtually every ASD but carries a longer recovery and the risks that come with any procedure on cardiopulmonary bypass. The anatomy decides. Not the preference.

“Parents come in wanting to know which option is better and I always tell them the same thing. The better option is the one your child’s anatomy makes possible and safe. Starting from a preference and working backwards to the anatomy is the wrong way around completely,“ says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India

Device closure works when the anatomy genuinely supports it and in those cases it’s a genuinely attractive option because it avoids open heart surgery entirely while achieving the same haemodynamic result if the defect sits in the right location with enough tissue rim around it.

• Secundum ASDs: The most common ASD type and the one most suitable for device closure because it sits in the middle of the atrial septum where catheter access is straightforward and where the tissue rim around the defect is usually adequate to anchor a device securely.
• Size matters: Defects up to around 38 to 40mm can potentially be closed by device but the ratio of defect size to total septal length matters as much as the raw measurement and that assessment only comes from a detailed echo in experienced hands.
• Rim adequacy: A defect with poor rim tissue near the aorta or the pulmonary veins can’t hold a device properly regardless of its size and deploying one anyway is how complications happen that a straightforward surgical repair would have avoided.
• Recovery difference: A child who has device closure goes home in one to two days, returns to normal activity within a week and carries no chest scar while a surgical repair means a week in hospital, six weeks of activity restriction and a sternotomy scar that lasts forever.

If your child has been told they have an ASD and needs assessment for the right closure approach, understanding what that decision involves starts with a proper atrial septal defect evaluation that maps the anatomy before anyone discusses options

When the anatomy rules device closure out. 

• Sinus venosus ASDs: These sit near the entry of the pulmonary veins and no catheter device can close them safely or effectively which makes surgical repair the only appropriate option regardless of how much a family might prefer to avoid open heart surgery.
• Large deficient rims: When the tissue border around the defect is too thin or absent in multiple directions a device has nothing solid to grip and the risk of embolisation or erosion into adjacent cardiac structures makes surgery the clearly safer path.
• Associated anomalies: Some ASDs come with partial anomalous pulmonary venous drainage or other structural problems that need direct surgical correction at the same time and a catheter in the femoral vein simply can’t address everything that needs fixing in that situation.
• Failed device attempt: Occasionally a device closure is attempted, the anatomy doesn’t cooperate and the procedure is abandoned in favour of surgery and a centre experienced in both approaches can pivot without the family losing time or the child losing ground.

Parents wanting to understand where unrepaired cardiac shunts eventually lead when they go unaddressed for too long should read this piece on when lung transplant becomes necessary for pulmonary hypertension because the pressure consequences of an untreated ASD don’t always wait as long as people assume.

An ASD assessment isn’t just measuring the hole. It’s reading the rim tissue, assessing the relationship to the pulmonary veins, understanding what the right atrium has already absorbed and then giving a family a clear answer about which approach is actually on the table for their child and why. Not a default recommendation. A real anatomical decision. Dr. Prashant Bobhate has spent over 12 years performing interventional paediatric cardiology including catheter-based ASD closures and managing the surgical planning pathway for defects that need open repair at the Children’s Heart Centre, Kokilaben Dhirubhai Ambani Hospital.

• Atrial Septal Defect, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/ency/article/000097.htm
• Congenital Heart Defects, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects